Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

China flag China · Delayed Price · Currency is CNY
4.130
-0.010 (-0.24%)
Apr 30, 2026, 3:04 PM CST
2.23%
Market Cap 4.93B
Revenue (ttm) 1.68B
Net Income (ttm) 62.86M
Shares Out 1.19B
EPS (ttm) 0.05
PE Ratio 84.48
Forward PE n/a
Dividend 0.04 (0.97%)
Ex-Dividend Date Sep 25, 2025
Volume 9,402,000
Average Volume 17,474,134
Open 4.070
Previous Close 4.140
Day's Range 4.070 - 4.170
52-Week Range 3.780 - 5.480
Beta 0.36
RSI 46.89
Earnings Date Apr 27, 2026

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the Peopl... [Read more]

Sector Healthcare
Founded 2004
Employees 3,392
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300194
Full Company Profile

Financial Performance

In 2025, SHE:300194's revenue was 1.74 billion, a decrease of -27.31% compared to the previous year's 2.39 billion. Earnings were 77.00 million, a decrease of -72.49%.

Financial Statements

News

There is no news available yet.